Skip to main content
Clinical Trials/NL-OMON35871
NL-OMON35871
Recruiting
N/A

ate effects: Insights into Cardiovascular disease risk after Hodgkin's lymphoma Treatment - LICHT

ederlands Kanker Instituut0 sites2,000 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular diseases
Sponsor
ederlands Kanker Instituut
Enrollment
2000
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
ederlands Kanker Instituut

Eligibility Criteria

Inclusion Criteria

  • \- 5 year Hodkin's Lymphoma survivors
  • \- treated in the Netherlands between 1965 and 2005

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials